Smith & Nephew CEO Olivier Bohuon is not only wary of a merger with another huge medical device company, but considers such speculation as a distraction.
“It has disrupted our sales force because every day they are with [competitors] who are saying, ‘By the way, we are going to buy you’,” Bohuon told The Financial Times in an article published Sunday.
The comments come a year after on-and-off-again speculation last year that Stryker was interested in the company. The Financial Times speculates that Johnson & Johnson, with its tens of billions of dollars in cash reserves, might be interested in a deal, too.
Help employers find you! Check out all the jobs and post your resume.
